Fig. 1From: Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathyExperimental design. Schematic timeline of the study design. BW body weight, ECHO echocardiogram, ECG electrocardiogram, Dox doxorubicin, IC intracavitary, CM-mESC cardiomyocytes derived from mouse embryonic stem cellBack to article page